Micro Labs Limited is a multi-faceted healthcare organization with a proficient marketing team, state-of-the-art manufacturing facilities and R&D centers that are at par with international standards. All this, robustly backed by a strong distribution network and path-breaking research work has placed us amongst India’s fast-growing transnational healthcare organizations.
Ranking 14th among prescriptions (as per SMSRC May 16' )and 19th in sales (as per AWACS MAT May’16) , Micro’s brand portfolio includes some of the topmost brands in various specialties like Cardiology, Diabetology, Anti-infectives, Ophthalmology, Pain, etc. Amidst our proud achievers is Dolo, an award-winning brand highly prescribed for fever management.
The company is also at the forefront of social contribution, striving to be a model corporate citizen in terms of Environmental Protection and Social Initiatives with significant contributions in the areas of education and health. Micro Labs is poised to achieve unparalleled status in the global pharmaceutical industry. Backed by a profound and resolute vision, we now have our eyes set on attaining the $1 billion mark by 2020.
The organization’s most important component, however, remains its 9200 dedicated employees. With state-of-the-art facilities and R&D centers designed to international standards, Micro Labs is poised to become a respected global brand in the pharmaceutical field and highlight our nation’s growing reputation.
The company today, has 20 marketing divisions catering to leading therapeutic segments such as Cardiology, Diabetology, Pain Management, Dermatology, Veterinary, Neurology, etc.
Micro Labs has been in a continuous stage of growth ever since it’s founding years and continues to chart its course as a leader in the pharmaceutical vertical. The company has a presence in over 30 countries with ground level operations in 15 countries, exporting all major dosages on most of the therapeutic segments. We are poised to have a quantum leap in our global operations, with the implementation of our growth strategies. The company currently operates in various countries of Asia, Europe, America & Africa.
Micro Labs has already established a strong presence in USA, UK, Russia, Ukraine, Nigeria, French West Africa, East Africa, Myanmar, Philippines, Vietnam, Thailand, Sri Lanka, etc. Latin America, North America, East Europe, Australia, New Zealand, Canada, and North Africa are locations where the company is raising its flag.
To complement our vision for global operations, company has established wholly owned subsidiaries in the USA (Micro Labs USA Inc.) , UK (Brown & Burk UK Ltd), Germany (Micro Labs GmbH), Australia (Micro Labs Pty Ltd) and Nigeria (Micro Nova Pharmaceuticals Ind Ltd). The Company has Representative Offices in many other parts of the world (emerging markets).
At Micro Labs, we are dedicated to developing top of the line pharmaceutical products, while adhering to the highest quality standards by a world-class research team. The continuous strive for perfection has led us to push our standards of manufacturing by building state-of-the-art facilities. Today these state-of-the-art manufacturing facilities and infrastructure facilitate Micro’s Organic Growth in the regulated markets.
The reason why Micro Labs has been able to have a successful run abroad is its world-class manufacturing units. Some of our facilities have been approved by the following regulatory authorities:
- Food & Drugs Control Administration (FDA)
- US Medicines & Healthcare products Regulatory Agency (MHRA)
- UK Health Canada World Health Organisation (WHO)
- Therapeutic Goods Authority (TGA)
- Australia Medsafe
- New Zealand Ministry of Health (MoH)